Showing posts with label pharma. Show all posts
Showing posts with label pharma. Show all posts

Thursday, February 27, 2014

Why a Retail Strategy is Critical to your Brand Success

In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy.

Thought Leader: Dick Domann, Vice President, Pharmacy Services, TrialCard Inc.

Play podcast

Monday, December 30, 2013

Biobetters: Challenges and Opportunities

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.

Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA

Play podcast

Thursday, November 14, 2013

Creating Great Multichannel CRM Experiences: Advice from a 28-year Pharma Expert

In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders.

Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems

Play podcast

Building Better Medication Adherence Models to Improve Health Outcomes

In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates.

Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris

Play podcast

Tuesday, October 02, 2012

What are ACOs and Why Should You Care?


Thought Leader: Anthony D. Slonim, MD, DrPH, Executive Vice President and Chief Medical Officer, Barnabas Health. Sponsored: by CMR Institute

In this episode, Dr. Slonim discusses ACOs, how they offer a new model for health care, how they create opportunities for biopharmaceutical companies, and how a shift to ACOs would affect all facets of the health care continuum.

For more information about CMR Institute, visit www.cmrinstitute.org.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Wednesday, January 04, 2012

Automating Pharma FCPA Due Diligence

Thought Leader: Robert Shecterle, Vice President of Marketing, Aravo

In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.